CALM Study: Cardiomems Assisted Lvad Management

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 20, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions
Heart Failure
Interventions
DEVICE

CardioMEMS Device

The CardioMEMS device will be implanted during a right heart catheterization procedure. The device will be positioned in the pulmonary artery and calibrated using a Swan-Ganz catheter. After implantation, PAP measurements will be taken daily using the home monitoring system provided to the patient. These readings will be transmitted wirelessly to the clinical team, who will review the data at least once per week. Adjustments to the patient's medical therapy and LVAD speed settings will be made based on the hemodynamic data provided by the CardioMEMS device.

Trial Locations (1)

75093

Baylor Scott & White The Heart Hospital - Plano, Plano

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER